YENIFER RODAS: Open Payments
NPI 1588347488 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 21 payments from 8 companies in 2025. Trend: 2023 $66 · 2024 $536 · 2025 $696
Food & beverage: $618Education: $78
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 10 | $380 |
| ABBVIE INC. | 2 | $96 |
| BeiGene USA, Inc. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| PFIZER INC. | 1 | $38 |
| Rigel Pharmaceuticals, Inc. | 2 | $35 |
| Eisai Inc. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
Products named: BRUKINSA, IMBRUVICA, CALQUENCE, TIVDAK, TAVALISSE, Lenvima, EPKINLY, VALCHLOR.
Industry payments across CA — which companies pay providers there.
